FDA Inspection
Piramal Pharma LimitedPiramal Pharma Limited – FDA Inspection, Feb 13, 2026
Record Details
This FDA Inspection record concerns Piramal Pharma Limited, with an inspection on February 13, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 9d76a7c9-b428-4f2e-a69d-3ef804424f97
Inspection Facts
- Inspection number
- 1308840
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Piramal Pharma Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 31, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 30, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 25, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 2, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Piramal Pharma Limited
- FDA Inspection 1204395 - 2023-03-31
- FDA Inspection 1049434 - 2018-03-30
- FDA Inspection 967695 - 2016-03-25
- FDA Inspection 863820 - 2014-01-20
- FDA Inspection 767041 - 2012-02-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.